Positron emission tomography with F‐18‐fluorodeoxyglucose to evaluate the results of hepatic chemoembolization

• Published in: Cancer Vol. 78; no. 10; pp. 2216 - 2222
• Main Authors: Vitola, João V., Delbeke, Dominique, Meranze, Steven G., Mazer, Murray J., Pinson, C. Wright
• Format: Journal Article Conference Proceeding
• Language: English
• Published: New York Wiley Subscription Services, Inc., A Wiley Company 15.11.1996; Wiley-Liss
• Subjects: Adenocarcinoma - diagnostic imaging; Adenocarcinoma - secondary; Adenocarcinoma - therapy; Biological and medical sciences; chemoembolization; Chemoembolization, Therapeutic; colorectal metastasis; Colorectal Neoplasms - pathology; Deoxyglucose - analogs & derivatives; emission computed tomography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; F‐18‐fluorodeoxyglucose; Gastroenterology. Liver. Pancreas. Abdomen; hepatic metastasis; Humans; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - secondary; Liver Neoplasms - therapy; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Male; Medical sciences; Middle Aged; Tomography, Emission-Computed; Tumors; Radionuclide study; Adenocarcinoma; Antineoplastic agent; Fluorine Complexes; Liver; Hepatic disease; Malignant tumor; Metastasis; Result; Chemotherapy; Treatment; Investigation method; Digestive diseases; Embolization; Intraarterial administration; Positron; Emission tomography

BACKGROUND Positron emission tomography (PET) using F‐18‐fluorodeoxyglucose (18FDG) is an imaging modality allowing direct evaluation of cellular glucose metabolism. The purpose of this study was to examine the role of 18FDG‐PET in monitoring chemoembolization therapy of patients with liver metastas...